Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to $11.8 million.

  • cbdMD's Liabilities and Shareholders Equity rose 207.18% to $11.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $43.0 million, marking a year-over-year decrease of 1481.27%. This contributed to the annual value of $10.4 million for FY2025, which is 152.63% down from last year.
  • As of Q4 2025, cbdMD's Liabilities and Shareholders Equity stood at $11.8 million, which was up 207.18% from $10.4 million recorded in Q3 2025.
  • cbdMD's 5-year Liabilities and Shareholders Equity high stood at $124.9 million for Q3 2021, and its period low was $9.9 million during Q2 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $24.6 million (2023), whereas its average is $43.9 million.
  • Per our database at Business Quant, cbdMD's Liabilities and Shareholders Equity skyrocketed by 1266.71% in 2021 and then crashed by 6733.6% in 2022.
  • cbdMD's Liabilities and Shareholders Equity (Quarter) stood at $99.3 million in 2021, then crashed by 64.03% to $35.7 million in 2022, then plummeted by 57.75% to $15.1 million in 2023, then dropped by 23.53% to $11.5 million in 2024, then grew by 2.07% to $11.8 million in 2025.
  • Its Liabilities and Shareholders Equity was $11.8 million in Q4 2025, compared to $10.4 million in Q3 2025 and $9.9 million in Q2 2025.